CN Stock MarketDetailed Quotes

688278 Xiamen Amoytop Biotech

Watchlist
  • 52.90
  • -0.65-1.21%
Market Closed Jul 1 15:00 CST
21.52BMarket Cap35.86P/E (TTM)

Xiamen Amoytop Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
41.17%1.14B
52.35%714.87M
60.16%345.01M
42.61%1.13B
Operating revenue
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
41.17%1.14B
52.35%714.87M
60.16%345.01M
42.61%1.13B
Total operating cost
24.66%379.69M
23.30%1.44B
14.73%996.11M
17.68%640.25M
17.61%304.58M
27.66%1.16B
37.93%868.24M
47.16%544.04M
53.25%258.97M
36.48%912M
Operating cost
0.09%37.77M
-17.24%140.05M
-23.25%93.62M
-14.77%63.82M
3.11%37.73M
35.25%169.24M
56.10%121.97M
62.07%74.88M
62.93%36.59M
49.59%125.13M
Operating tax surcharges
31.27%2.79M
43.30%11.24M
40.40%7.91M
37.43%4.83M
33.38%2.13M
37.25%7.84M
38.74%5.63M
42.17%3.51M
43.65%1.6M
43.82%5.71M
Operating expense
29.96%241.91M
20.71%848.8M
10.21%602.43M
15.81%413.04M
7.31%186.14M
17.67%703.15M
29.01%546.63M
46.56%356.67M
59.42%173.46M
39.40%597.56M
Administration expense
29.70%54.39M
51.98%210.31M
58.10%152.37M
40.23%83.08M
49.70%41.94M
34.11%138.38M
43.17%96.38M
50.51%59.24M
42.69%28.01M
38.64%103.19M
Financial expense
30.08%-750.94K
-15.10%-4.81M
8.94%-3.08M
20.35%-1.73M
-3.25%-1.07M
-282.73%-4.18M
-472.87%-3.38M
-592.79%-2.17M
-406.67%-1.04M
-228.13%-1.09M
-Interest expense (Financial expense)
-2.77%114.11K
-18.46%506.17K
-25.11%371.36K
-28.61%249.63K
-37.44%117.36K
-42.23%620.73K
48.02%495.87K
--349.65K
--187.59K
-56.36%1.07M
-Interest Income (Financial expense)
25.64%-975.13K
-45.04%-6.63M
-34.96%-4.79M
-24.37%-3.11M
4.18%-1.31M
-60.22%-4.57M
-93.75%-3.55M
-151.77%-2.5M
-356.16%-1.37M
-2.48%-2.85M
Research and development
15.55%43.58M
53.48%229.98M
41.44%142.86M
48.74%77.21M
85.34%37.71M
83.83%149.84M
77.66%101.01M
34.39%51.91M
18.41%20.35M
6.30%81.51M
Credit Impairment Loss
135.01%127.38K
-132.95%-463.8K
13.87%-620.78K
-518.11%-1.01M
-1,028.37%-363.79K
-39.22%1.41M
-167.33%-720.71K
-113.54%-163.51K
-95.10%39.19K
186.69%2.32M
Asset Impairment Loss
----
---12.76M
----
----
----
----
----
----
----
----
Other net revenue
Fair value change income
----
566.55%2.65M
-86.27%163.84K
-76.82%107.04K
----
-77.89%397.64K
-76.67%1.19M
-87.58%461.71K
-98.85%21.25K
-54.60%1.8M
Invest income
-26.34%1.4M
0.74%3.55M
5.72%2.26M
5.52%1.9M
47.80%1.9M
-29.38%3.52M
2,523.70%2.14M
2,106.53%1.8M
1,475.31%1.28M
464.46%4.99M
Asset deal income
--44.95K
-90.80%8.84K
-91.49%8.17K
-94.34%4.31K
----
216.07%96.06K
364.21%96.06K
302.42%76.21K
----
-12.33%30.39K
Other revenue
21.96%3.33M
-40.87%22.98M
-55.84%15.2M
-85.99%4.31M
68.24%2.73M
102.70%38.87M
591.13%34.42M
754.84%30.8M
3.41%1.62M
-28.38%19.17M
Operating profit
43.30%170.52M
67.28%680.72M
54.03%480.68M
31.82%268.64M
33.69%118.99M
63.73%406.92M
62.92%312.08M
88.40%203.79M
75.49%89.01M
57.16%248.53M
Add:Non operating Income
188.13%501.72K
47.52%453.06K
182.29%279.61K
241.61%243.14K
310.17%174.13K
85.15%307.12K
-18.93%99.05K
134.88%71.17K
189.29%42.45K
-2.56%165.87K
Less:Non operating expense
-10.58%13.65M
-21.02%40.52M
-26.15%33.29M
-22.88%22.22M
-7.43%15.26M
53.57%51.31M
68.59%45.08M
72.53%28.82M
87.00%16.49M
73.61%33.41M
Total profit
51.46%157.37M
80.00%640.65M
67.61%447.67M
40.91%246.66M
43.19%103.9M
65.33%355.93M
61.93%267.09M
91.32%175.05M
73.10%72.56M
54.81%215.29M
Less:Income tax cost
44.77%28.56M
23.65%85.21M
18.11%78.77M
7.45%44.48M
30.58%19.73M
102.16%68.91M
79.03%66.69M
113.47%41.39M
96.23%15.11M
51.50%34.09M
Net profit
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
67.90%57.45M
55.44%181.2M
Net profit from continuing operation
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
67.90%57.45M
55.44%181.2M
Net profit of parent company owners
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
67.90%57.45M
55.44%181.2M
Earning per share
Basic earning per share
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
58.06%0.49
83.33%0.33
75.00%0.14
55.17%0.45
Diluted earning per share
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
58.06%0.49
83.33%0.33
75.00%0.14
55.17%0.45
Other composite income
Total composite income
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
67.90%57.45M
55.44%181.2M
Total composite income of parent company owners
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
67.90%57.45M
55.44%181.2M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B41.17%1.14B52.35%714.87M60.16%345.01M42.61%1.13B
Operating revenue 30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B41.17%1.14B52.35%714.87M60.16%345.01M42.61%1.13B
Total operating cost 24.66%379.69M23.30%1.44B14.73%996.11M17.68%640.25M17.61%304.58M27.66%1.16B37.93%868.24M47.16%544.04M53.25%258.97M36.48%912M
Operating cost 0.09%37.77M-17.24%140.05M-23.25%93.62M-14.77%63.82M3.11%37.73M35.25%169.24M56.10%121.97M62.07%74.88M62.93%36.59M49.59%125.13M
Operating tax surcharges 31.27%2.79M43.30%11.24M40.40%7.91M37.43%4.83M33.38%2.13M37.25%7.84M38.74%5.63M42.17%3.51M43.65%1.6M43.82%5.71M
Operating expense 29.96%241.91M20.71%848.8M10.21%602.43M15.81%413.04M7.31%186.14M17.67%703.15M29.01%546.63M46.56%356.67M59.42%173.46M39.40%597.56M
Administration expense 29.70%54.39M51.98%210.31M58.10%152.37M40.23%83.08M49.70%41.94M34.11%138.38M43.17%96.38M50.51%59.24M42.69%28.01M38.64%103.19M
Financial expense 30.08%-750.94K-15.10%-4.81M8.94%-3.08M20.35%-1.73M-3.25%-1.07M-282.73%-4.18M-472.87%-3.38M-592.79%-2.17M-406.67%-1.04M-228.13%-1.09M
-Interest expense (Financial expense) -2.77%114.11K-18.46%506.17K-25.11%371.36K-28.61%249.63K-37.44%117.36K-42.23%620.73K48.02%495.87K--349.65K--187.59K-56.36%1.07M
-Interest Income (Financial expense) 25.64%-975.13K-45.04%-6.63M-34.96%-4.79M-24.37%-3.11M4.18%-1.31M-60.22%-4.57M-93.75%-3.55M-151.77%-2.5M-356.16%-1.37M-2.48%-2.85M
Research and development 15.55%43.58M53.48%229.98M41.44%142.86M48.74%77.21M85.34%37.71M83.83%149.84M77.66%101.01M34.39%51.91M18.41%20.35M6.30%81.51M
Credit Impairment Loss 135.01%127.38K-132.95%-463.8K13.87%-620.78K-518.11%-1.01M-1,028.37%-363.79K-39.22%1.41M-167.33%-720.71K-113.54%-163.51K-95.10%39.19K186.69%2.32M
Asset Impairment Loss -------12.76M--------------------------------
Other net revenue
Fair value change income ----566.55%2.65M-86.27%163.84K-76.82%107.04K-----77.89%397.64K-76.67%1.19M-87.58%461.71K-98.85%21.25K-54.60%1.8M
Invest income -26.34%1.4M0.74%3.55M5.72%2.26M5.52%1.9M47.80%1.9M-29.38%3.52M2,523.70%2.14M2,106.53%1.8M1,475.31%1.28M464.46%4.99M
Asset deal income --44.95K-90.80%8.84K-91.49%8.17K-94.34%4.31K----216.07%96.06K364.21%96.06K302.42%76.21K-----12.33%30.39K
Other revenue 21.96%3.33M-40.87%22.98M-55.84%15.2M-85.99%4.31M68.24%2.73M102.70%38.87M591.13%34.42M754.84%30.8M3.41%1.62M-28.38%19.17M
Operating profit 43.30%170.52M67.28%680.72M54.03%480.68M31.82%268.64M33.69%118.99M63.73%406.92M62.92%312.08M88.40%203.79M75.49%89.01M57.16%248.53M
Add:Non operating Income 188.13%501.72K47.52%453.06K182.29%279.61K241.61%243.14K310.17%174.13K85.15%307.12K-18.93%99.05K134.88%71.17K189.29%42.45K-2.56%165.87K
Less:Non operating expense -10.58%13.65M-21.02%40.52M-26.15%33.29M-22.88%22.22M-7.43%15.26M53.57%51.31M68.59%45.08M72.53%28.82M87.00%16.49M73.61%33.41M
Total profit 51.46%157.37M80.00%640.65M67.61%447.67M40.91%246.66M43.19%103.9M65.33%355.93M61.93%267.09M91.32%175.05M73.10%72.56M54.81%215.29M
Less:Income tax cost 44.77%28.56M23.65%85.21M18.11%78.77M7.45%44.48M30.58%19.73M102.16%68.91M79.03%66.69M113.47%41.39M96.23%15.11M51.50%34.09M
Net profit 53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M67.90%57.45M55.44%181.2M
Net profit from continuing operation 53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M67.90%57.45M55.44%181.2M
Net profit of parent company owners 53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M67.90%57.45M55.44%181.2M
Earning per share
Basic earning per share 52.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.7158.06%0.4983.33%0.3375.00%0.1455.17%0.45
Diluted earning per share 52.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.7158.06%0.4983.33%0.3375.00%0.1455.17%0.45
Other composite income
Total composite income 53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M67.90%57.45M55.44%181.2M
Total composite income of parent company owners 53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M67.90%57.45M55.44%181.2M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg